Literature DB >> 12057159

Recurrent or persistent thyroid cancer of follicular cell origin.

M Duren1, Q Y Duh, A E Siperstein, O H Clark.   

Abstract

Most patients with differentiated thyroid cancer of follicular cell origin have a favorable postoperative course, and their prognosis often appears to be unrelated to the extent of initial surgical treatment in some studies. Important questions that need to be addressed include whether the extent of the initial operation has any impact on the subsequent tumor-free survival and total survival, and whether patients with persistent or recurrent disease benefit from reoperation.

Entities:  

Mesh:

Year:  2000        PMID: 12057159     DOI: 10.1007/s11864-000-0049-2

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  29 in total

1.  Current results of conservative surgery for differentiated thyroid carcinoma.

Authors:  R L Rossi; B Cady; M L Silverman; M S Wool; T A Horner
Journal:  World J Surg       Date:  1986-08       Impact factor: 3.352

2.  Papillary carcinoma of the thyroid. I. Developing pattern of metastasis.

Authors:  S Noguchi; A Noguchi; N Murakami
Journal:  Cancer       Date:  1970-11       Impact factor: 6.860

3.  Changing end results in patients with papillary carcinoma of the thyroid.

Authors:  G Crile
Journal:  Surg Gynecol Obstet       Date:  1971-03

4.  The enucleation of thyroid tumors indeterminate before surgery as papillary thyroid carcinoma: should immediate reoperation be performed?

Authors:  K Sugino; K Ito; T Mimura; O Ozaki; M Kawano; Y Kitamura; H Iwabuchi
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

5.  Serum TSH levels in therapy of thyroid carcinoma.

Authors:  J I Hamburger
Journal:  J Nucl Med       Date:  1980-05       Impact factor: 10.057

6.  External radiotherapy and radionuclide in the treatment of thyroid cancer.

Authors:  M Tubiana
Journal:  World J Surg       Date:  1981-01       Impact factor: 3.352

7.  TSH suppression in the management of thyroid nodules and thyroid cancer.

Authors:  O H Clark
Journal:  World J Surg       Date:  1981-01       Impact factor: 3.352

8.  Recurrent thyroid cancer. Role of surgery versus radioactive iodine (I131)

Authors:  M Coburn; D Teates; H J Wanebo
Journal:  Ann Surg       Date:  1994-06       Impact factor: 12.969

9.  Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma.

Authors:  M Schlumberger; M Tubiana; F De Vathaire; C Hill; P Gardet; J P Travagli; P Fragu; J Lumbroso; B Caillou; C Parmentier
Journal:  J Clin Endocrinol Metab       Date:  1986-10       Impact factor: 5.958

10.  Treatment of locally advanced thyroid carcinoma with combination doxorubicin and radiation therapy.

Authors:  J H Kim; R D Leeper
Journal:  Cancer       Date:  1987-11-15       Impact factor: 6.860

View more
  1 in total

1.  Application of carbon nanoparticles for parathyroid protection in reoperation of thyroid diseases.

Authors:  Bo Gao; Wuguo Tian; Yan Jiang; Shu Zhang; Lingji Guo; Jianjie Zhao; Gang Zhang; Shuai Hao; Yan Xu; Donglin Luo
Journal:  Int J Clin Exp Med       Date:  2015-12-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.